QT Imaging Taps Digital Health Veteran as CSO to Drive AI and Quantitative Imaging Strategy
Event summary
- QT Imaging appointed Dr. Julia Albright as Chief Science Officer on July 27, 2026.
- Dr. Albright brings 25 years of experience in medical imaging, digital health, and AI-powered image analysis.
- She will lead scientific strategy, partnering across R&D, engineering, clinical, and product teams.
- Previously held senior roles at Canon Medical Systems, GE HealthCare, and Amazon Web Services.
The big picture
QT Imaging's appointment of Dr. Julia Albright as CSO underscores its shift from a scanner company to a scalable precision imaging platform. Her background in medical imaging, digital health, and AI positions her to drive innovation in quantitative breast imaging and evidence generation. This move aligns with broader industry trends toward AI-driven diagnostics and personalized healthcare solutions.
What we're watching
- AI Integration
- How Dr. Albright's expertise in AI-powered image analysis will accelerate QT Imaging's platform evolution.
- Strategic Alignment
- Whether the new CSO can ensure alignment between scientific strategy and product roadmap as QT Imaging scales.
- Clinical Evidence
- The pace at which QT Imaging can expand its clinical evidence base under Dr. Albright's leadership.